Annals of Thoracic Medicine
GUIDELINES
Year
: 2008  |  Volume : 3  |  Issue : 6  |  Page : 97--99

Systemic therapy in non-small-cell lung cancer


Abdul-Rahman Jazieh1, Ahmed Saadeen2 
1 King Abdulaziz Medical City for National Guard, Riyadh, Saudi Arabia
2 Riyadh Military Hospital, Riyadh, Saudi Arabia

Correspondence Address:
Abdul-Rahman Jazieh
Department of Oncology (Mail code 1777) P.O. Box 22490, Riyadh 11426
Saudi Arabia

The systemic treatment of lung cancer has evolved rapidly over the last two decades. Systemic therapy has become the standard of care for advanced lung cancer up to the third line. The addition of antiangiogenesis agents to chemotherapy has proved to be beneficial in the first-line setting. Finally, systemic therapy has proven effective in the adjuvant setting in early-stage lung cancer.


How to cite this article:
Jazieh AR, Saadeen A. Systemic therapy in non-small-cell lung cancer.Ann Thorac Med 2008;3:97-99


How to cite this URL:
Jazieh AR, Saadeen A. Systemic therapy in non-small-cell lung cancer. Ann Thorac Med [serial online] 2008 [cited 2022 Sep 27 ];3:97-99
Available from: https://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2008;volume=3;issue=6;spage=97;epage=99;aulast=Jazieh;type=0